Axsome’s Therapy for Agitation in Alzheimer’s Granted FDA Fast Track Designation – WhosGonnaTakeCareOfMe

Music Therapy Decreases Medication Use and Improves Dementia Symptoms, Study Finds

Preventing Diabetes May Help Halt Alzheimer’s Progression in New York State, Report Says

Axsome’s Therapy for Agitation in Alzheimer’s Granted FDA Fast Track Designation

Axsome Therapeutics’ investigational drug AXS-05 was recently granted fast track designation by the U.S. Food and Drug Administration (FDA) for the treatment of agitation in patients with Alzheimer’s disease.

Butch Grimes